Centre Léon Bérard, Lyon, France.
Crit Rev Oncol Hematol. 2011 Feb;77(2):142-7. doi: 10.1016/j.critrevonc.2010.01.015. Epub 2010 Feb 24.
Oncologists usually base treatment decision on the assessment of patients' performance status (PS). This study was undertaken to explore the ability of KPS to correctly assess the PS of elderly cancer patients, comparing it to a validated geriatric tool named Physical Performance Test (PPT). One single examiner assessed elderly cancer patients' PS at registration in our institution and performed the PPT on patients with KPS ≥ 60. A sample of 152 patients actually underwent PPT. A low refusal rate was observed (<5%). Most patients (82%) had a high PS (KPS ≥ 80), whereas only 20% had no health impairment according to PPT scores. Patients' gender and disease stage did not correlate with PPT scores. The KPS seems to be a less accurate tool than the PPT to assess functional status of elderly cancer patients. Then PPT could be used as an inclusion criterion instead of KPS before cancer treatment decision.
肿瘤医生通常根据患者的体能状态（PS）评估来制定治疗决策。本研究旨在通过与一种名为体能表现测试（PPT）的已验证的老年综合评估工具进行比较，来探讨 KPS 正确评估老年癌症患者 PS 的能力。由一名单一评估者在我院登记时评估老年癌症患者的 PS，并对 KPS≥60 的患者进行 PPT 测试。共有 152 例患者实际接受了 PPT 测试。观察到低拒绝率（<5%）。大多数患者（82%）PS 较高（KPS≥80），而根据 PPT 评分，仅有 20%的患者没有健康受损。患者的性别和疾病分期与 PPT 评分无关。KPS 似乎不如 PPT 准确，无法评估老年癌症患者的功能状态。因此，在制定癌症治疗决策之前，PPT 可作为纳入标准，而非 KPS。
